Previous Close | 1.9300 |
Open | 1.9400 |
Bid | 1.3700 x 200 |
Ask | 2.4400 x 200 |
Day's Range | 1.7000 - 1.9498 |
52 Week Range | 1.6200 - 4.2700 |
Volume | |
Avg. Volume | 11,298 |
Market Cap | 78.993M |
Beta (5Y Monthly) | 0.23 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.1600 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 5.50 |
HOLLISTER, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, following the close of market. Teknova will host a webcast and conference call on Monday, May 13, 2024, beginni
The heavy selling pressure might have exhausted for Alpha Teknova (TKNO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Alpha Teknova, Inc. (NASDAQ:TKNO) Q4 2023 Earnings Call Transcript March 12, 2024 Alpha Teknova, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and thank you for standing by. Welcome to Teknova Fourth Quarter 2023 Financial Results Conference Call. […]